DGX - Quest Diagnostics Incorporated

NYSE - NYSE Delayed Price. Currency in USD

Quest Diagnostics Incorporated

500 Plaza Drive
Secaucus, NJ 07094
United States
973 520 2700
http://www.questdiagnostics.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees46,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Stephen H. RusckowskiChairman, Pres & CEO2.2MN/A1957
Mr. Mark J. GuinanExec. VP & CFON/AN/A1962
Ms. Catherine T. DohertySr. VP and Group Exec. of Clinical Franchise Solutions & Marketing819.21k1.1M1963
Mr. James E. DavisExec. VP of Gen. Diagnostics866.62k2.97M1963
Ms. Carrie Eglinton MannerSr. VP of Advanced Diagnostics1.14MN/A1975
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic testing information and services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also offers risk assessment services for the life insurance industry; and health information technology solutions for healthcare organizations and clinicians. Quest Diagnostics Incorporated has a strategic collaboration with hc1. The company was founded in 1967 and is headquartered in Secaucus, New Jersey.

Corporate Governance

Quest Diagnostics Incorporated’s ISS Governance QualityScore as of October 4, 2019 is 4. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 3; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.